Effect of beta-blocker therapy on the risk of infections and death after acute stroke - A historical cohort study

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Maier, Ilko L ^a   Karch, André ^b   Mikolajczyk, Rafael ^b,c   Bähr, Mathias ^a   Liman, Jan ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL;

AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PNEUMONIA; RISK REDUCTION; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; COMPLICATION; IMMUNOLOGY; INFECTION; STROKE; TREATMENT OUTCOME;

MUS;

ADRENERGIC BETA-ANTAGONISTS; AGED; COHORT STUDIES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFECTION; MALE; STROKE; TREATMENT OUTCOME;

EID: 84922214600     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116836     Document Type: Article

References (31)

1. Koennecke HC, Belz W, Berfelde D, Endres M, Fitzek S et al. (2011) Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology 77: 965-972. doi: 10.1212/WNL.0b013e31822dc795 PMID: 21865573
2. Steinman L (2004) Elaborate interactions between the immune and nervous systems. Nat Immunol 5: 575-581. PMID: 15164017
3. Finlayson O, Kapral M, Hall R, Asllani E, Selchen D et al. (2011) Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology 77: 1338-1345. doi: 10.1212/WNL.0b013e31823152b1 PMID: 21940613
4. Westendorp WF, Nederkoorn PJ, Vermeij JD, Dijkgraaf MG, van de Beek D (2011) Post-stroke infection: a systematic review and meta-analysis. BMC Neurol 11: 110. doi: 10.1186/1471-2377-11-110 PMID: 21933425
5. Galea I, Bechmann I, Perry VH (2007) What is immune privilege (not)? Trends Immunol 8: 12-18.
6. Chen GY, Nuñez G (2010) Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10: 826-837. doi: 10.1038/nri2873 PMID: 21088683
7. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA et al. (2006) Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 5: 654-665. PMID: 16121126
8. Schroeter M, Jander S, Witte OW, Stoll G (1994) Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J Neuroimmunol 55: 195-203. PMID: 7530260
9. Chamorro A, Urra X, Planas AM (2007) Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 38: 1097-1103. PMID: 17255542
10. Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17: 796-808. doi: 10.1038/nm.2399 PMID: 21738161
11. Chamorro Á, Meisel A, Planas AM, Urra X, van de Beek D et al. (2012) The immunology of acute stroke. Nat Rev Neurol 8: 401-410. doi: 10.1038/nrneurol.2012.98 PMID: 22664787
12. Klehmet J, Harms H, Richter M, Prass K, Volk HD et al. (2009) Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 158: 1184-1193. doi: 10.1016/j.neuroscience.2008.07.044 PMID: 18722511
13. Seki Y, Sahara Y, Itoh E, Kawamura T (2010) Suppressed neutrophil respiratory burst in patients with haemorrhagic stroke. J Clin Neurosci 17: 187-190. doi: 10.1016/j.jocn.2009.04.020 PMID: 20006511
14. Harms H, Reimnitz P, Bohner G, Werich T, Klingebiel R et al. (2011) Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection. Cerebrovasc Dis 32: 552-560. doi: 10.1159/000331922 PMID: 22104620
15. Ay H, Koroshetz WJ, Benner T, Vangel MG, Melinosky C et al. (2006) Neuroanatomic correlates of stroke-related myocardial injury. Neurology 66: 1325-1329. PMID: 16525122
16. Wong CH, Jenne CN, Lee WY, Léger C, Kubes P (2011) Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 334: 101-105. doi: 10.1126/science.1210301 PMID: 21921158
17. Textor J, Hardt J, Knüppel S (2011) DAGitty: A Graphical Tool for Analyzing Causal Diagrams. Epidemiology 5: 745.
18. Herz J, Hagen SI, Bergmüller E, Sabellek P, Göthert JR et al. (2014) Exacerbation of ischemic brain injury in hypercholesterolemic mice is associated with pronounced changes in peripheral and cerebral immune responses. Neurobiol Dis 62: 456-68. doi: 10.1016/j.nbd.2013.10.022 PMID: 24184800
19. Miida T, Hirayama S, Nakamura Y (2004) Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia. J Atheroscler Thromb 1: 253-64.
20. Brossay L, Naidenko O, Burdin N, Matsuda J, Sakai T et al. (1998) Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. J Immunol 161: 5124-8. PMID: 9820479
21. Macchia A, Romero M, Comignani PD, Mariani J, D'Ettorre A et al. (2012) Previous prescription of beta-blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis. Crit Care Med 40: 2768-2772. PMID: 22824934
22. Oberbeck R, Kobbe P (2009) Beta-adrenergic antagonists: indications and potential immunomodulatory side effects in the critically ill. Curr Med Chem 16: 1082-1090. PMID: 19275613
23. Muthu K, He LK, Szilagyi A, Stevenson J, Gamelli RL et al. (2009) Propranolol restores the tumor necrosis factor-alpha response of circulating inflammatory monocytes and granulocytes after burn injury and sepsis. J Burn Care Res 30: 8-18. doi: 10.1097/BCR.0b013e3181921f22 PMID: 19060758
24. Ackland GL, Yao ST, Rudiger A, Dyson A, Stidwill R et al. (2010) Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats. Crit Care Med 38: 388-394. doi: 10.1097/CCM.0b013e3181c03dfa PMID: 19829100
25. Barer DH, Cruickshank JM, Ebrahim SB, Mitchell JR (1988) Low dose beta blockade in acute stroke ("BEST" trial): an evaluation. Br Med J (Clin Res Ed) 296: 737-741. PMID: 3126956
26. Dziedzic T, Slowik A, Pera J, Szczudlik A (2007) Beta-blockers reduce the risk of early death in ischemic stroke. J Neurol Sci 252: 53-56. PMID: 17134722
27. Laowattana S, Oppenheimer SM (2007) Protective effects of beta-blockers in cerebrovascular disease. Neurology 68: 509-514. PMID: 17296916
28. Platzer C, Döcke W, Volk H, Prösch S (2000) Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells. J Neuroimmunol 105: 31-38. PMID: 10713361
29. Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG (2007) Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis 7: 358-68. PMID: 17448939
30. Weber MS, Prod'homme T, Steinman L, Zamvil SS (2005) Drug Insight: using statins to treat neuroinflammatory disease. Nat Clin Pract Neurol 1: 106-12. PMID: 16932506
31. Fehr T, Kahlert C, Fierz W, Joller-Jemelka HI, Riesen WF et al. (2004) Statin-induced immunomodulatory effects on human T cells in vivo. Atherosclerosis 175: 83-90. PMID: 15186950